ALLEGRO PHARMACEUTICALS INC has a total of 44 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2010. It filed its patents most often in Australia, China and Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are THROMBOTARGETS EUROPE SL, ANNEXIN PHARMACEUTICALS AB and 3D MATRIX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | China | 5 | |
#3 | Japan | 4 | |
#4 | Republic of Korea | 4 | |
#5 | United States | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 4 | |
#7 | Israel | 3 | |
#8 | Brazil | 2 | |
#9 | Canada | 2 | |
#10 | EPO (European Patent Office) | 2 | |
#11 | Hong Kong | 2 | |
#12 | New Zealand | 2 | |
#13 | Russian Federation | 2 | |
#14 | South Africa | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Object sterilising | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Mackel Michael John | 28 |
#2 | Park John | 17 |
#3 | Park John Y | 16 |
#4 | Karageozian Hampar L | 16 |
#5 | Karageozian Vicken H | 16 |
#6 | Michael John Mackel | 7 |
#7 | John Park | 5 |
#8 | John Y Park | 3 |
#9 | Karageozian Vicken | 3 |
#10 | Hampar L Karageozian | 3 |
Publication | Filing date | Title |
---|---|---|
WO2018236931A1 | Peptide compositions and related methods | |
KR20190107147A | Integrin receptor antagonists and their methods of use | |
WO2011060104A2 | Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites |